← Leaderboards
Thomas J Abbruscato
Texas Tech University Health Scis Center
$7,448,916
Attributed
$13,035,893
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,035,893 · 6
By mechanism
R01$13,035,893 · 6
Top collaborators
- Luca Cucullo15 shared
- Vardan T. Karamyan6 shared
- Paul Trippier6 shared
Most similar at Texas Tech University Health Scis Center
Same institution · by research overlap
- Vardan T. Karamyan$1,187,161
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeBlood - Brain Barrier AnatomyBrainIn VivoInjuryCerebral IschemiaProteinsEdemaBrain InjuriesMediatingIn VitroIschemic StrokeResponsePublishingDoseIschemic Brain InjuryMolecularInfarctionNeuronsCerebrovascularRecoveryChronicNicotinePathway Interactions
Grant awards (31)
Development and Characterization of Small Molecule Activators of Peptidase Neurolysin for Stroke Therapy$645,589
R01 · FY2025 · NS
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$568,452
R01 · FY2024 · NS · contact PI
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$586,033
R01 · FY2023 · NS · contact PI
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$586,033
R01 · FY2022 · NS · contact PI
Development and Characterization of Peptidomimetic Small Molecule Activators of Peptidase Neurolysin for Stroke Therapy$578,588
R01 · FY2022 · NS
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$586,033
R01 · FY2021 · NS · contact PI
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$578,745
R01 · FY2021 · NS
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette Products$450,440
R01 · FY2021 · DA · contact PI
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2021 · DA · contact PI
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$595,334
R01 · FY2020 · NS · contact PI
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$578,745
R01 · FY2020 · NS
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette Products$454,762
R01 · FY2020 · DA · contact PI
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2020 · DA · contact PI
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$113,362
R01 · FY2020 · DA
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$578,745
R01 · FY2019 · NS
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette Products$459,000
R01 · FY2019 · DA
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2019 · DA
Investigations into the effects of sex and age on tobacco smoke and e-Cigarette toxicity at the blood-brain barrier and stroke outcome.$113,362
R01 · FY2019 · DA
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.$601,070
R01 · FY2018 · NS
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2018 · DA
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2017 · DA
Increased sodium dependent glucose transport in the ischemic brain$290,812
R01 · FY2015 · NS · contact PI
Increased sodium dependent glucose transport in the ischemic brain$283,104
R01 · FY2014 · NS · contact PI
Increased sodium dependent glucose transport in the ischemic brain$283,525
R01 · FY2013 · NS · contact PI
Increased sodium dependent glucose transport in the ischemic brain$300,462
R01 · FY2012 · NS · contact PI
Increased sodium dependent glucose transport in the ischemic brain$366,657
R01 · FY2011 · NS · contact PI
Tobacco Smoke Chemicals and Stroke Alter Brain K+ Efflux$293,050
R01 · FY2008 · NS · contact PI
Tobacco Smoke Chemicals and Stroke Alter Brain K+ Efflux$293,050
R01 · FY2007 · NS · contact PI
Tobacco Smoke Chemicals and Stroke Alter Brain K+ Efflux$301,802
R01 · FY2006 · NS · contact PI
Tobacco Smoke Chemicals and Stroke Alter Brain K+ Efflux$309,066
R01 · FY2005 · NS
Tobacco Smoke Chemicals and Stroke Alter Brain K+ Efflux$327,572
R01 · FY2004 · NS